DE3873525T2 - Verwendung von 2,4-monofurfuryliden-sorbitol und dessen tetraalkyl-derivaten in kosmetika und in der dermatologie. - Google Patents
Verwendung von 2,4-monofurfuryliden-sorbitol und dessen tetraalkyl-derivaten in kosmetika und in der dermatologie.Info
- Publication number
- DE3873525T2 DE3873525T2 DE8888107813T DE3873525T DE3873525T2 DE 3873525 T2 DE3873525 T2 DE 3873525T2 DE 8888107813 T DE8888107813 T DE 8888107813T DE 3873525 T DE3873525 T DE 3873525T DE 3873525 T2 DE3873525 T2 DE 3873525T2
- Authority
- DE
- Germany
- Prior art keywords
- monofurfurylidene
- alkyl groups
- sorbitol
- cosmetics
- tetraalkylsorbitol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 10
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 title description 7
- 239000000600 sorbitol Substances 0.000 title description 7
- 239000000203 mixture Substances 0.000 claims abstract description 33
- YZNXOCVTNIERFC-UHFFFAOYSA-N 1-[2-(furan-2-yl)-5-hydroxy-6-(hydroxymethyl)-1,3-dioxan-4-yl]ethane-1,2-diol Chemical compound O1C(CO)C(O)C(C(O)CO)OC1C1=CC=CO1 YZNXOCVTNIERFC-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000006071 cream Substances 0.000 claims abstract description 8
- 230000005855 radiation Effects 0.000 claims abstract description 7
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 5
- 239000003344 environmental pollutant Substances 0.000 claims abstract description 5
- 206010063493 Premature ageing Diseases 0.000 claims abstract description 4
- 239000000499 gel Substances 0.000 claims abstract description 4
- 239000006210 lotion Substances 0.000 claims abstract description 4
- 239000007921 spray Substances 0.000 claims abstract description 3
- 239000002304 perfume Substances 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 16
- 230000009759 skin aging Effects 0.000 claims description 5
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 4
- 231100000719 pollutant Toxicity 0.000 claims description 3
- 239000004264 Petrolatum Substances 0.000 claims description 2
- 150000002334 glycols Chemical class 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 229940066842 petrolatum Drugs 0.000 claims description 2
- 235000019271 petrolatum Nutrition 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 229940099259 vaseline Drugs 0.000 description 11
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 235000013871 bee wax Nutrition 0.000 description 6
- 239000012166 beeswax Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 5
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 239000001632 sodium acetate Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- DWANEFRJKWXRSG-UHFFFAOYSA-N 1,2-tetradecanediol Chemical compound CCCCCCCCCCCCC(O)CO DWANEFRJKWXRSG-UHFFFAOYSA-N 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 208000032038 Premature aging Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000000779 smoke Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 1
- JZSMZIOJUHECHW-GTJZZHROSA-N 2-hydroxypropyl (z,12r)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC(=O)OCC(C)O JZSMZIOJUHECHW-GTJZZHROSA-N 0.000 description 1
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 1
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
- SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 description 1
- 206010029098 Neoplasm skin Diseases 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- NWGKJDSIEKMTRX-BFWOXRRGSA-N [(2r)-2-[(3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)C1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-BFWOXRRGSA-N 0.000 description 1
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 1
- 230000002225 anti-radical effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 229940049638 carbomer homopolymer type c Drugs 0.000 description 1
- 229940082484 carbomer-934 Drugs 0.000 description 1
- 229940043234 carbomer-940 Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 239000003546 flue gas Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 229940072106 hydroxystearate Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- -1 polycyclic hydrocarbons Chemical class 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT20707/87A IT1205111B (it) | 1987-05-28 | 1987-05-28 | Impiego del 2,4-monofurfuriliden-sorbitolo ad uso cosmetico |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3873525D1 DE3873525D1 (de) | 1992-09-10 |
| DE3873525T2 true DE3873525T2 (de) | 1992-12-10 |
Family
ID=11170863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE8888107813T Expired - Lifetime DE3873525T2 (de) | 1987-05-28 | 1988-05-16 | Verwendung von 2,4-monofurfuryliden-sorbitol und dessen tetraalkyl-derivaten in kosmetika und in der dermatologie. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0345362B1 (enExample) |
| AT (1) | ATE79022T1 (enExample) |
| CA (1) | CA1323573C (enExample) |
| DE (1) | DE3873525T2 (enExample) |
| ES (1) | ES2034018T3 (enExample) |
| GR (1) | GR3006118T3 (enExample) |
| IT (1) | IT1205111B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE150960T1 (de) * | 1992-08-26 | 1997-04-15 | Beiersdorf Ag | Verwendung von radikalfängern als immunmodulierende agentien in kosmetischen und dermatologischen zubereitungen |
| DE4305788C2 (de) * | 1993-02-25 | 1997-06-12 | Beiersdorf Ag | Kosmetische und dermatologische Formulierungen zum Schutze der Haut gegen Oxidationsprozesse |
| ITMI20050151A1 (it) * | 2005-02-03 | 2006-08-04 | Lab Fitocosmesi & Farmaceuti C | Monoesteri di acidi grassi del sorbitil furfurale e relative composizioni per uso cosmetico e dermatologico |
| US9889132B2 (en) | 2014-07-04 | 2018-02-13 | Special Product's Line S.p.A. | Pharmaceutical compositions for the treatment of psoriasis |
| LT3274347T (lt) | 2015-03-26 | 2020-12-10 | Giuliani S.P.A. | Junginiai, turintys antioksidacinį aktyvumą prieš laisvuosius radikalus ir priešuždegiminį aktyvumą, ir atitinkamos farmacinės kompozicijos, skirtos odos priežiūrai |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3383279A (en) * | 1965-05-18 | 1968-05-14 | Inst Chemioterapico Italiana S | Method of treatment comprising administration of sorbitol-furfural condensation product and pharmaceutical composition including said condensation product |
| DE2331821A1 (de) * | 1973-06-22 | 1975-01-23 | Henkel & Cie Gmbh | Entuendungshemmer fuer kosmetische praeparationen |
-
1987
- 1987-05-28 IT IT20707/87A patent/IT1205111B/it active
-
1988
- 1988-05-16 EP EP88107813A patent/EP0345362B1/en not_active Expired - Lifetime
- 1988-05-16 DE DE8888107813T patent/DE3873525T2/de not_active Expired - Lifetime
- 1988-05-16 AT AT88107813T patent/ATE79022T1/de not_active IP Right Cessation
- 1988-05-16 ES ES198888107813T patent/ES2034018T3/es not_active Expired - Lifetime
- 1988-05-27 CA CA000567930A patent/CA1323573C/en not_active Expired - Lifetime
-
1992
- 1992-10-30 GR GR920402445T patent/GR3006118T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0345362A1 (en) | 1989-12-13 |
| IT8720707A0 (it) | 1987-05-28 |
| CA1323573C (en) | 1993-10-26 |
| ES2034018T3 (es) | 1993-04-01 |
| IT1205111B (it) | 1989-03-15 |
| GR3006118T3 (enExample) | 1993-06-21 |
| EP0345362B1 (en) | 1992-08-05 |
| ATE79022T1 (de) | 1992-08-15 |
| DE3873525D1 (de) | 1992-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69326776T2 (de) | Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress | |
| DE3650068T2 (de) | Pharmazeutische träger zum reduzieren des transdermalen flusses. | |
| DE69710571T2 (de) | Mikrokabeln aus chitin oder chitinderivaten, die eine hydrophobe substanz, insbesondere ein sonnenschutzfilter enthalten, und methode zur herstellung solcher mikrokapseln | |
| DE69201510T2 (de) | Verwendung von Lysin und/oder Arginin Pyrrolidone-Carboxylate als Antioxidationsmittel in Kosmetika oder Pharmazeutika. | |
| DE69807070T2 (de) | Tocoferol estern und deren verwendung in kosmetika und pharmazie | |
| DE69429513T2 (de) | Polyphenolderivatzusammensetzungen und deren herstellung | |
| DE69411812T2 (de) | Kosmetisches oder pharmazeutisches Präparat zur topischer Verwendung gegen freien Radikale | |
| DE2102172C3 (de) | Neue Mittel zur Behandlung und Pflege der Haut | |
| DE3415413C2 (enExample) | ||
| DE2707878C2 (de) | Verwendung von Mono- und/oder Diglyceriden mittelkettiger Fettsäuren | |
| DE69217206T2 (de) | Benzopyranphenolderivate zur verwendung als immunstimulierende mittel | |
| DE2129654C3 (de) | Medikament zur Verminderung der Kapillarpermeabilität und Erhöhung der Kapillarstabilität aus der Extraktion der Flavanole enthaltenden Früchte von Vitis vinifera | |
| DE2734823C2 (de) | Sonnenschutzmittel | |
| DE2459914C2 (de) | Verfahren zur Herstellung von N-Hydroxyalkyl-p-aminobenzoaten und diese Verbindungen enthaltende Sonnenschutzmittel | |
| DE3408362C2 (de) | Arzneimittel mit antineoplastischer Wirkung | |
| DE2514878C3 (de) | Allantoin-Ascorbinsäure-Komplexe | |
| DE3543496A1 (de) | 4-methoxy-2'-carboxydibenzoylmethan und dessen salze | |
| DE3042491A1 (de) | Niedermolekulare polysaccaride aus pflanzen der compositen-familie, verfahren zu ihrer gewinnung und sie enthaltende pharmazeutische zubereitungen | |
| DE2032914A1 (enExample) | ||
| DE69120992T2 (de) | Alkyldiamide und kosmetische Behandlungszusammensetzungen | |
| CA1323573C (en) | Use of 2, 4-monofufurylidene-sorbitol and its tetraalkyl derivatives in cosmetics and dermatology | |
| CH643807A5 (de) | Ultraviolette strahlen absorbierendes mittel. | |
| DE69524720T2 (de) | Dermatologische zubereitungen | |
| EP1022017B1 (de) | Kosmetische oder pharmazeutische Zubereitungen für die topische Verabreichung mit verbesserter Stabilität | |
| US5135946A (en) | Use of 2,4 monofurfurylidene-sorbitol and its tetraalkyl derivatives in cosmetics and dermatology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |